Baiyunshan Pharmaceutical is a comprehensive pharmaceutical research and development company
Baiyunshan Pharmaceutical is a comprehensive pharmaceutical research and development company, the company's business includes "Great Southern Medicine", "Great Health", "Great Business" and "Great Medical" four business segments, the main products include Quenching Thirst Pills, Angong Niuhuang Pills, Wanglaoji herbal tea, etc. In addition, the company is also engaged in health management, health care and retirement and other health industry investment.
GlaxoSmithKline in China: Challenges Faced
China is undoubtedly the largest source of income for multinational pharmaceutical enterprises, and it is also the market they attach the most importance to. This article mainly analyzes the annual report of GSK to study its development in China and the challenges it faces.
Aug 15, 2022 02:31 AM
ResearchHealthcare, Technology, Consumer Staples
WIA2020 | Rising Tech Stars 2020: Global & China's 100
ResearchReal Estate, Industrials, Financials
Tech for Global, Globalization Footprints of the Established and the New
Gilead Reached USD 455 Mn Contract with Everest for Asian Rights
The company said it would use the money to fund additional dealmaking activities, clinical development of Calliditas Therapeutics-partnered kidney disease drug Nefecon in several Asia countries and other pipeline assets.
Aug 16, 2022 05:47 PM
Bennu Biotherapeutics Bags Over CNY 100 Mn in Angel+ Financing Round
Biotech Bennu Biotherapeutics, focusing on the R&D and conversion of cutting-edge technologies in the cell therapy, will continue to contribute to global innovative cellular therapies for oncology and autoimmune diseases with the fresh proceeds.
Aug 15, 2022 05:19 PM